Health Policy and Technology

卫生政策与技术（HPT）是跨学科期刊研究生医学奖学金（FPM）的官方期刊，重点关注过去，现在和未来的卫生政策以及技术在临床和非临床国家中的作用和国际健康环境。HPT为FPM继续为医学和相关学科的政策和实践发展做出重要的国家和国际贡献提供了更好的途径。 HPT的目的是发布相关，及时和可访问的文章和评论，以支持对卫生政策和技术感兴趣的政策制定者，卫生专业人员，卫生技术提供者，患者团体和学术界。HPT涵盖的主题包括： - 卫生技术，包括药物发现，诊断，药物，设备，治疗传递和电子卫生保健系统 - 使用基于证据的方法对卫生政策进行跨国比较 - 关于卫生政策的国家研究，以确定技术驱动举措的成果 - 跨境电子卫生保健，包括健康旅游 - 医疗保健的移动性，可及性和可负担性方面的数字鸿沟 - 用于评估临床和非临床卫生技术有效性的卫生技术评估（HTA）方法和工具 - 用于了解卫生技术的采用和传播的健康和电子卫生保健指标和基准（衡量标准/指标） - 卫生和电子卫生保健模型和框架，以支持政策制定者和其他利益相关者参与决策 - 利益相关者参与卫生技术（临床和患者/公民买入） - 监管和卫生经济学

Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments.HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology.Topics covered by HPT will include:- Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems- Cross-national comparisons on health policy using evidence-based approaches- National studies on health policy to determine the outcomes of technology-driven initiatives- Cross-border eHealth including health tourism- The digital divide in mobility, access and affordability of healthcare- Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies- Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies- Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making- Stakeholder engagement with health technologies (clinical and patient/citizen buy-in)- Regulation and health economics